Delivery Order SPE2DR25D3201-SPE2DR26FT4UL
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,329.04 to AmerisourceBergen Drug Corp for the supply of BRILINTA 60 mg tablets (60-count packages). This non-set-aside, competitively awarded contract features firm fixed pricing and was executed on September 5, 2025, with an ultimate completion date of September 8, 2025. The pharmaceutical products will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order valued at $2,623.19 to AmerisourceBergen Drug Corp for the supply of BRILINTA 60 mg tablets (60-count package). This non-set-aside, competitively awarded contract utilizes firm fixed-price pricing and is scheduled for completion by June 13, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the work at its corporate office location in the same city. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of BRILINTA 60 mg tablets (60-count units) under a firm fixed-price contract valued at $12,518.91. The order was competitively awarded without set-aside designation and is scheduled for completion by October 28, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for supply of BRILINTA 60 mg tablets (60-count packages) with a ceiling value of $2,125.24. This non-set-aside, firm fixed-price delivery order is scheduled for ultimate completion by December 5, 2025, with performance originating from the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of BRILINTA 60 mg tablets (60-count packages) with a contract value of $16,251.94. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded on November 28, 2025, with an ultimate completion date of December 1, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Brilinta 60 mg tablets (60-count units) under a firm fixed-price contract with a ceiling value of $1,758.96. The award, issued on November 3, 2025, is set to be completed by November 4, 2025. This delivery order represents a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for BRILINTA 90 mg tablets (60-count) with a ceiling value of $7,078.10 under a firm fixed-price contract type. The order was issued on September 18, 2025, with an ultimate completion date of September 19, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is fulfilling this order from its corporate office location, which serves as...
- The Defense Logistics Agency awarded a delivery order valued at $3,936.12 to AmerisourceBergen Drug Corp on November 25, 2025, for the supply of Brilinta 60 mg tablets (60-count). The award was competitively procured with no set-aside designation and carries a firm fixed price structure with an ultimate completion date of November 26, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this contract at its Corporate Office location. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,170.36 to AmerisourceBergen Drug Corp for the supply of Brilinta 90 mg tablets (60-count units) under a firm fixed price arrangement. This is a non-set-aside, competitively awarded contract with a completion date of December 11, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of BRILINTA 60 mg tablets (60-count units) under a firm fixed-price contract valued at $3,329.04. The delivery order was awarded on August 22, 2025, with an ultimate completion date of August 25, 2025, and represents a non-set-aside, competitively awarded procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- SPE2DR25D3201Indefinite Delivery Contract
- SPE2DR25D3201-SPE2DR26FT4ULDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,307.63 to AmerisourceBergen Drug Corp for the supply of BRILINTA 90 mg tablets (60-count packages). This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by December 18, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will fulfill this pharmaceutical supply requirement from its corporate office location. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This master contract vehicle enables comprehensive pharmaceutical support to military healthcare systems globally, encompassing a broad range of medications, vaccines, and medical supplies across multiple therapeutic domains. BRILINTA, an antiplatelet medication used in cardiovascular care, represents a critical pharmaceutical commodity within this broader defense healthcare supply framework supporting the Defense Health Agency and other federal medical programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.3k | 12/16/25 |